NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDDalteparin  Cardiovascular system, Low molecular weight heparins, 02.08.01
SCGEnoxaparin
(Bedford site Obstetric patients) 		Cardiovascular system, Low molecular weight heparins, 02.08.01
REDEnoxaparin
(for L&D site Obstetric patients) 		Cardiovascular system, Low molecular weight heparins, 02.08.01
 Tinzaparin  Cardiovascular system, Low molecular weight heparins, 02.08.01
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Bemiparin Bemiparin Sodium Cardiovascular System, Blood Clots, Thromboembolism, Antithrombotic Drugs Heparins
Dalteparin Dalteparin Sodium Cardiovascular System, Blood Clots, Thromboembolism, Antithrombotic Drugs Heparins
Dalteparin Dalteparin Sodium Cardiovascular System, Myocardial Ischaemia, Acute Coronary Syndromes, Antithrombotic Drugs Heparins
Enoxaparin Enoxaparin Sodium Cardiovascular System, Blood Clots, Thromboembolism, Antithrombotic Drugs Heparins
Enoxaparin Enoxaparin Sodium Cardiovascular System, Myocardial Ischaemia, Acute Coronary Syndromes, Antithrombotic Drugs Heparins
Heparin  Heparin (Unfractionated) Cardiovascular System, Blood Clots, Blocked Catheters And Lines, Antithrombotic Drugs Heparins
Heparin  Heparin (Unfractionated) Cardiovascular System, Blood Clots, Thromboembolism, Antithrombotic Drugs Heparins
Heparin  Heparin (Unfractionated) Cardiovascular System, Myocardial Ischaemia, Acute Coronary Syndromes, Antithrombotic Drugs Heparins
Tinzaparin Tinzaparin Sodium Cardiovascular System, Blood Clots, Thromboembolism, Antithrombotic Drugs Heparins
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
JPC Bulletin 242 : Low Molecular Weight Heparins (LMWHs) and Fondaparinux – Prescribing Guidance (Feb 20)